About this FactMed analysis covering adverse side effect reports of ACETONE patients who developed DEATH.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 3 individuals taking ACETONE reported DEATH to the FDA. A total of 31 ACETONE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACETONE and DEATH. In doing so, we compare ACETONE with other drugs that cause DEATH, to help you evaluate whether or not ACETONE causes DEATH. Likewise, this page shows the most highly-reported side effects of ACETONE, so you can see if DEATH ranks among ACETONE's most well-known side effects.
Summary Statistics
Reports of ACETONE causing DEATH: 3
Reports of any side effect of ACETONE : 31
Percentage of ACETONE patients where DEATH is a reported side effect: 9.6774%

FDA reports of any drug causing DEATH : 157069
Average percentage for all medicated patients where DEATH is reported as a complication: 0.9844%

Physician opinion on ACETONE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACETONE:
HYPERTENSION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with DEATH:

REVLIMID (9475 patients)
DIANEAL (6739 patients)
TRASYLOL (6596 patients)
TRACLEER (5718 patients)
AVANDIA (5236 patients)
THALOMID (5161 patients)
VIOXX (4842 patients)
EXJADE (4630 patients)
ASPIRIN (4029 patients)
GLEEVEC (3904 patients)
ZOMETA (3699 patients)
SEROQUEL (3295 patients)
LASIX (3257 patients)
LIPITOR (3164 patients)
LETAIRIS (3012 patients)
SUTENT (2787 patients)
COUMADIN (2609 patients)
AVONEX (2603 patients)
REVATIO (2391 patients)
FORTEO (2192 patients)
PLAVIX (2146 patients)
EXTRANEAL (2106 patients)
DEXAMETHASONE (2036 patients)
OXYCONTIN (2014 patients)
AVASTIN (2011 patients)
PREDNISONE (1996 patients)
REMODULIN (1993 patients)
FUROSEMIDE (1947 patients)
HEPARIN (1918 patients)
XELODA (1904 patients)
ZOLEDRONOC ACID (1853 patients)
LUCENTIS (1830 patients)
REMICADE (1821 patients)
CLOZARIL (1741 patients)
CLOZAPINE (1726 patients)
FOSAMAX (1691 patients)
DIGOXIN (1686 patients)
LISINOPRIL (1665 patients)
ACETAMINOPHEN (1609 patients)
NORVASC (1468 patients)
ZYPREXA (1432 patients)
OMEPRAZOLE (1429 patients)
NEXIUM (1414 patients)
TARCEVA (1398 patients)
VELCADE (1360 patients)
NPLATE (1338 patients)
DIOVAN (1330 patients)
FOLIC ACID (1285 patients)
SANDOSTATIN LAR (1264 patients)
EXELON (1250 patients)
METHOTREXATE (1177 patients)
CAPECITABINE (1163 patients)
FENTANYL (1146 patients)
CELEBREX (1131 patients)
LYRICA (1129 patients)
NITROGLYCERIN (1116 patients)
POTASSIUM CHLORIDE (1112 patients)
RECLAST (1104 patients)
MORPHINE (1089 patients)
ATENOLOL (1089 patients)
SIMVASTATIN (1078 patients)
INSULIN (1075 patients)
SPIRIVA (1068 patients)
HUMIRA (1058 patients)
SYNTHROID (1056 patients)
RISPERDAL (1054 patients)
CYCLOPHOSPHAMIDE (1035 patients)
PRADAXA (987 patients)
ALBUTEROL (982 patients)
LANTUS (980 patients)
OXYCODONE HCL (976 patients)
PREDNISOLONE (951 patients)
ZOCOR (942 patients)
ADVAIR DISKUS 100/50 (936 patients)
ALLOPURINOL (936 patients)
LORAZEPAM (921 patients)
AREDIA (910 patients)
PROTONIX (902 patients)
ALPRAZOLAM (892 patients)
WARFARIN SODIUM (880 patients)
ZOLOFT (876 patients)
NEURONTIN (868 patients)
PRILOSEC (854 patients)
PROGRAF (849 patients)
BEVACIZUMAB (833 patients)
VANCOMYCIN (830 patients)
METFORMIN HCL (822 patients)
PREDNISONE TAB (816 patients)
RED BLOOD CELLS (814 patients)
DECADRON (806 patients)
PROTAMINE SULFATE (804 patients)
DURAGESIC-100 (800 patients)
MORPHINE SULFATE (795 patients)
GABAPENTIN (790 patients)
AFINITOR (788 patients)
TOPROL-XL (787 patients)
FLUOROURACIL (785 patients)
RITUXIMAB (781 patients)
NEXAVAR (771 patients)
ATIVAN (770 patients)
ZOFRAN (770 patients)
VITAMIN D (769 patients)
AMBIEN (769 patients)
CARBOPLATIN (766 patients)
CLONAZEPAM (766 patients)
COREG (752 patients)
XANAX (751 patients)
IBANDRONIC ACID (746 patients)
CISPLATIN (740 patients)
TYSABRI (733 patients)
ACLASTA (729 patients)
ENBREL (718 patients)
DIAZEPAM (697 patients)
CYMBALTA (687 patients)
OXALIPLATIN (686 patients)
VENTAVIS (685 patients)
LOVENOX (684 patients)
IBUPROFEN (681 patients)
AMLODIPINE (674 patients)
LEVAQUIN (658 patients)
GEMZAR (637 patients)
SPIRONOLACTONE (619 patients)
PAXIL (618 patients)
ARANESP (617 patients)
VERSED (612 patients)
VIDAZA (611 patients)
CORTICOSTEROIDS (601 patients)
PROCRIT (601 patients)
TACROLIMUS (599 patients)
OXYGEN (586 patients)
PREVACID (581 patients)
TEMAZEPAM (576 patients)
PLATELETS (572 patients)
LEXAPRO (558 patients)
BETASERON (558 patients)
TRAMADOL HCL (553 patients)
TAXOTERE (550 patients)
VICODIN (542 patients)
CRESTOR (541 patients)
METOPROLOL (539 patients)
ACYCLOVIR (538 patients)
DIANEAL PD-2 W/ DEXTROSE 1.5% (537 patients)
GLUCOPHAGE (535 patients)
PERCOCET (529 patients)
CALCIUM (529 patients)
TYKERB (523 patients)
MULTI-VITAMINS (519 patients)
DIOVAN HCT (510 patients)
VFEND (510 patients)
AMIODARONE HCL (509 patients)
DOXORUBICIN HCL (509 patients)
LOPRESSOR (503 patients)
BONIVA (495 patients)
FEMARA (492 patients)
CLONIDINE (492 patients)
ATROVENT (491 patients)
ALDACTONE (490 patients)
MEGACE (490 patients)
TAXOL (487 patients)
VITAMIN B-12 (485 patients)
PEGASYS (474 patients)
LIDOCAINE (465 patients)
ABILIFY (464 patients)
EPINEPHRINE (463 patients)
SUNITINIB MALATE (460 patients)
VIAGRA (460 patients)
GLIPIZIDE (455 patients)
METHADONE HCL (453 patients)
FLUCONAZOLE (450 patients)
TASIGNA (448 patients)
DILAUDID (446 patients)
LANSOPRAZOLE (445 patients)
PANTOPRAZOLE (445 patients)
LANOXIN (444 patients)
DOPAMINE HCL (442 patients)
METOCLOPRAMIDE (434 patients)
IMATINIB MESYLATE (433 patients)
RAMIPRIL (433 patients)
CYCLOSPORINE (431 patients)
PROMACTA (428 patients)
LIORESAL (425 patients)
DOCETAXEL (424 patients)
ALIMTA (423 patients)
TOBI (421 patients)
LACTULOSE (419 patients)
FLOMAX (418 patients)
VINCRISTINE (416 patients)
ACTIVASE (412 patients)
NEUPOGEN (411 patients)
RANIBIZUMAB (411 patients)
ETOPOSIDE (408 patients)
TRAZODONE HCL (407 patients)
MABTHERA (406 patients)
MANNITOL (406 patients)
COZAAR (405 patients)
GLYBURIDE (405 patients)
BENADRYL (404 patients)
MULTI-VITAMIN (402 patients)
HUMALOG (402 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.

Recent FactMed Activity for ACETONE

Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about DEATH and ACETONE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACETONE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACETONE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACETONE experts. If you are a healthcare provider experienced in prescribing ACETONE, please register here.

Your online appointment book for Lancaster Rentals & Services

Chef and Catering services in Lancaster
Chiropracter and Massage services in Lancaster
Event and Wedding Planning services in Lancaster
Hair Styling services in Lancaster
Personal Shopping services in Lancaster
Photography and Videography services in Lancaster
Private Investigation services in Lancaster
Website Design services in Lancaster

Appliance Repair services in Lancaster
Appraisals services in Lancaster
Awnings services in Lancaster
Builder Services services in Lancaster
Carpentry services in Lancaster
Cleaning services in Lancaster
Decks and Porches services in Lancaster
Electricians services in Lancaster
Fireplace services in Lancaster
Generators services in Lancaster
Greenhouses and Nurseries services in Lancaster
Handymen services in Lancaster
Home Security services in Lancaster
HVAC services in Lancaster
Insulation services in Lancaster
Interior Design services in Lancaster
Landscaping services in Lancaster
Lawn and Yard services in Lancaster
Locksmiths services in Lancaster
Marble and Granite Experts services in Lancaster
Masonry services in Lancaster
Moving Services services in Lancaster
Painters services in Lancaster
Plumbing services in Lancaster
Pool and Spa services in Lancaster
Property Management services in Lancaster
Roofers services in Lancaster
Snow Plowing services in Lancaster
Solar Power Consultants services in Lancaster
Upholstery services in Lancaster
Wallpaper services in Lancaster
Waterproofing services in Lancaster
Windows services in Lancaster
Services - Other

© 2014 FactMed, Inc
Privacy Policy
Terms of Use